Atopic Dermatitis

Scientific Publications

References
  1. Boguniewicz M, Fonacier L, Guttman-Yassky E, Ong PY, Silverberg J, Farrar JR. Atopic dermatitis yardstick: Practical recommendations for an evolving therapeutic landscape. Ann Allergy Asthma Immunol. 2018;120:10-22.e2. https://www.annallergy.org/action/showPdf?pii=S1081-1206(17)31260-7
  2. Boguniewicz M, Alexis AF, Beck LA, et al. Expert perspectives on management of moderate-to-severe atopic dermatitis: A multidisciplinary consensus addressing current and emerging therapies. J Allergy Clin Immunol Pract. 2017;5:1519-1531. https://www.ncbi.nlm.nih.gov/pubmed/28970084
  3. Brunner PM, Silverberg JI, Guttman-Yassky E, et al. Increasing comorbidities suggest that atopic dermatitis is a systemic disorder. J Invest Dermatol. 2017;137:18-25. https://www.ncbi.nlm.nih.gov/pubmed/27771048
  4. DaVeiga SP. Epidemiology of atopic dermatitis: A review. Allergy Asthma Proc. 2012;33:227-234. https://www.ncbi.nlm.nih.gov/pubmed/22584191
  5. Drucker AM, Wang AR, Li WQ, Sevetson E, Block JK, Qureshi AA. The burden of atopic dermatitis: Summary of a report for the national eczema association. J Invest Dermatol. 2017;137:26-30. https://www.ncbi.nlm.nih.gov/pubmed/27616422
  6. Egeberg A, Andersen YM, Gislason GH, Skov L, Thyssen JP. Prevalence of comorbidity and associated risk factors in adults with atopic dermatitis. Allergy. 2017;72:783-791. https://www.ncbi.nlm.nih.gov/pubmed/27864954
  7. Eichenfield LF, Ahluwalia J, Waldman A, Borok J, Udkoff J, Boguniewicz M. Current guidelines for the evaluation and management of atopic dermatitis: A comparison of the Joint Task Force Practice Parameter and American Academy of Dermatology guidelines. J Allergy Clin Immunol. 2017;139(4 suppl):S49-S57. https://www.ncbi.nlm.nih.gov/pubmed/28390477
  8. Eichenfield LF, Tom WL, Chamlin SL, et al. Guidelines of care for the management of atopic dermatitis: Section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol. 2014;70:338-351. https://www.ncbi.nlm.nih.gov/pubmed/24290431
  9. Montes-Torres A, Llamas-Velasco M, Pérez-Plaza A, Solano-López G, Sánchez-Pérez J. Biological treatments in atopic dermatitis. J Clin Med. 2015;4:593-613. https://pubmed.ncbi.nlm.nih.gov/26239349/
  10. Paller AS, Kabashima K, Bieber T. Therapeutic pipeline for atopic dermatitis: End of the drought? J Allergy Clin Immunol. 2017;140:633-643. https://www.ncbi.nlm.nih.gov/pubmed/28887947
  11. Renert-Yuval Y, Guttman-Yassky E. Systemic therapies in atopic dermatitis: The pipeline. Clin Dermatol. 2017;35:387-397. https://www.ncbi.nlm.nih.gov/pubmed/28709570
  12. Silverberg JI. Healthcare utilization, patient costs, and access to care in US adults with eczema: A population-based study. JAMA Dermatol. 2015;151:743-752. https://www.ncbi.nlm.nih.gov/pubmed/25738422
  13. Thyssen JP, Hamann CR, Linneberg A, et al. Atopic dermatitis is associated with anxiety, depression, and suicidal ideation, but not with hospitalization or suicide. Allergy. 2018;73:214-220. https://www.ncbi.nlm.nih.gov/pubmed/28632893
  14. Wei W, Anderson P, Gadkari A, et al. Discordance between physician- and patient-reported disease severity in adults with atopic dermatitis: A US cross-sectional survey. Am J Clin Dermatol. 2017;18:825-835. https://www.ncbi.nlm.nih.gov/pubmed/28447213
  15. Werfel T, Allam JP, Biedermann T, et al. Cellular and molecular immunologic mechanisms in patients with atopic dermatitis. J Allergy Clin Immunol. 2016;138:336-349. https://www.ncbi.nlm.nih.gov/pubmed/27497276
  16. Zhang A, Silverberg JI. Association of atopic dermatitis with being overweight and obese: A systematic review and metaanalysis. J Am Acad Dermatol. 2015;72:606-616. https://www.ncbi.nlm.nih.gov/pubmed/25773409
Scroll to Top